MEI Pharma CEO Daniel Gold's 2020 pay jumps 22% to $2.3M

MEI Pharma reports 2020 executive compensation

By ExecPay News

Published: October 27, 2020

MEI Pharma reported fiscal year 2020 executive compensation information on October 27, 2020.
In 2020, four MEI Pharma executives received on average a compensation package of $1.3M, a 11% increase compared to previous year.
Average pay of disclosed executives at MEI Pharma
Daniel P. Gold, Chief Executive Officer, received $2.3M in total, which increased by 22% compared to 2019. 50% of Gold's compensation, or $1.1M, was in option awards. Gold also received $195K in bonus, $293K in non-equity incentive plan, as well as $650K in salary.
David M. Urso, Chief Operating Officer, received a compensation package of $1.3M, which decreased by 1% compared to previous year. 45% of the compensation package, or $576K, was in option awards.
Brian G. Drazba, Chief Financial Officer, earned $982K in 2020, a 17% increase compared to previous year.
Robert D. Mass, Chief Medical Officer, received $673K in 2020, which is about the same as previous year.
MEI Pharma's fiscal year ends on June 30.

Related executives

Daniel Gold

MEI Pharma

Chief Executive Officer

Brian Drazba

MEI Pharma

Chief Financial Officer

Robert Mass

MEI Pharma

Chief Medical Officer

David Urso

MEI Pharma

Chief Operating Officer

You may also like

Source: SEC filing on October 27, 2020.